Rutgers Cancer Institute, along with its partner
RWJBarnabas Health
, offers the most advanced cancer treatment options including complex robotic surgery, clinical trials and novel therapeutics such as precision medicine, CAR T-Cell Therapy and other forms of immunotherapy.
|
|
|
$2.3 Million in American Cancer Society Grants Awarded to Rutgers Cancer Institute Researchers
|
|
|
|
More than $2.3 million in Research Scholar Grants from the American Cancer Society have been awarded to three Rutgers Cancer Institute of New Jersey researchers to examine cell metabolism and tumor formation in forms of breast cancer, lung cancer and leukemia. Grants of $792,000 each were awarded to
Michael L. Gatza, PhD
,
Yanxiang Jessie Guo, PhD
, and
Daniel Herranz Benito, PhD
, who are also faculty members at Rutgers Robert Wood Johnson Medical School. The aim is to better understand these cell mechanisms, offering a foundation for the development of future therapies.
Learn more
|
|
|
|
During the month of November, the National Hockey League celebrated
Hockey Fights Cancer
during which each team hosted a special event to raise awareness for the fight against cancer. The New Jersey Devils supported this initiative during their November 23 game against the Detroit Red Wings. As part of the effort, the Devils signed 10-year-old brain cancer survivor, Grace Eline to a one-day contract for the game. She joined the Devils at practice, was fitted with her own hockey equipment and jersey and joined the team on ice. Grace was treated at Rutgers Cancer Institute of New Jersey and Newark Beth Israel Medical Center, an RWJBarnabas Health facility. RWJBarnabas Health is the official health care provider of the New Jersey Devils.
Learn more
|
|
$150K Pledge from Om Foundation Supports Pediatric Cancer Research
|
|
|
|
A $150,000 pledge from the Om Foundation will aid investigators at Rutgers Cancer Institute of New Jersey in examining a certain type of medication that impacts gene activity in the treatment of a form of pediatric brain cancer. Rutgers Cancer Institute pediatric hematologist/ oncologist
Maxim Yankelevich, MD
, who is an associate professor of pediatrics at Rutgers Robert Wood Johnson Medical School and principal investigator of the work, notes study results may provide necessary data to develop new treatment strategies in treating ependymoma, the third most common childhood brain cancer.
Learn more
|
|
Examining Molecular Evolution and Treatment Impact in Leukemia
|
|
|
|
Rutgers Cancer Institute of New Jersey researcher
Hossein Khiabanian, PhD
,
has received a $600,000 Translational Award from the V Foundation for Cancer Research to study chronic lymphocytic leukemia (CLL). Dr. Khiabanian, who is also an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, aims to develop research models that may help investigators better understand how CLL cells are influenced by new therapies.
Learn more
|
|
Bruce G. Haffty, MD Named Chair of Radiological Society of North America Board
|
|
|
|
Bruce G. Haffty, MD
, associate vice chancellor of cancer programs at Rutgers Cancer Institute of New Jersey, was named chair of the Radiological Society of North America (RSNA) Board of Directors at the Society's annual meeting in Chicago earlier this month. Dr. Haffty, who also serves as professor and chair in the Department of Radiation Oncology at Rutgers Cancer Institute, Rutgers Robert Wood Johnson Medical School and Rutgers New Jersey Medical School, specializes in the treatment of breast cancer and is a national leader in radiation oncology and clinical trials.
Learn more
|
|
|
|
|
|
|
